Viewing Study NCT00956293


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2025-12-25 @ 11:28 PM
Study NCT ID: NCT00956293
Status: TERMINATED
Last Update Posted: 2014-06-06
First Post: 2009-08-07
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program
Sponsor: Novartis Pharmaceuticals
Organization: